Bausch+Lomb has recycled more than five million units of contact lens materials through its program’s second anniversary, Opticianreports.
The company’s ‘One by One’ recycling program for used contact lenses, blister packs and top foils has diverted a weight of nearly 31,000 pounds of waste away from landfills.
Ms Amy Butler, vice president of Global Environment, Health, Safety + Sustainability at Bauch Health said: “Up until two years ago, there wasn’t a program that allowed contact lens wearers to properly dispose of or recycle their contact lens materials without ensuring they did not end up in our environment.
“By providing this solution to eye-care professionals and their patients, we are making strides to protect our environment from used contact lens materials and instead turning them into a variety of post-consumer products, such as recycled picnic tables and garden beds.”
Silhouette has won the 2019 edition of the German Design Award.
This international award was presented by the German Design Council, whose mission is ‘to discover, showcase and recognize design trends’.
Safilo has started employing 100% nickel-free production processes in its Longarone Italy plant.
Two years after beginning laboratory tests in nickel-free production, the company has developed nickel-free and non-cyanide galvanic processes that are now fully verified and employed throughout all its production lines.
Contact lens manufacturerr Tangible Science has announced the United States Food and Drug Administration has cleared the first daily disposable silicone hydrogel contact lens coated with a modified formula of Tangible Hydra-PEG.
Tangible Hydra-PEG is a coating applied to custom contact lenses to improve lens wettability and deposit resistance, and the new lens utilises a variation designed to enhance the surface of daily wear lenses.
The new coated silicone hydrogel lens is designed to retain more water and stay cleaner during daily wear than an uncoated lens.
Wetter and cleaner lenses are associated with greater patient comfort during wear, according to Tangible Science.
The new coated lens is made from a very soft material to maximize comfort on the eye. The contact lens material also has one of the highest levels of oxygen permeability available in a disposable lens, which can enhance corneal health and further improve comfort, the company said in a statement.
The original Tangible Hydra-PEG coating is widely used to improve the lens wearing experience for custom contact lens wearers, as custom lenses are made of hard materials which can be uncomfortable and can attract deposits, the company said. While daily disposable lenses are made of softer material, many patients still experience discomfort due to dry eyes, extended mobile device use, use of
Read More >
Alcon, a division of Novartis, has acquired Tear Film Innovations, Inc. a privately-held company and manufacturer of the iLux Device, an innovative therapeutic device used to treat Meibomian Gland Dysfunction, a leading cause of dry eye.
Hand-held and portable, the iLux device enables eye-care professionals to directly target a patient’s blocked meibomian glands and provide therapy through an in-office treatment.
The Tear Film acquisition expands Alcon’s portfolio of ocular-health products, including several treatments for the temporary relief of dry eye symptoms.
Using the iLux Device, a practitioner can warm the eyelids via disposable silicone pads to address blocked meibomian glands through the application of light-based heating. While applying the iLux device, the practitioner can view the eyelid margin and apply manually-controlled compression to express blockages, making adjustments as needed to tailor treatment to the individual needs of the patient.
Most treatments can be completed in a matter of minutes.
The iLux Device received 510(k) clearance from the U.S. Food and Drug Administration in December 2017, and was officially launched by Tear Film in May 2018 at the annual meeting of the American Society for Cataract and Refractive Surgery.
The Zeiss Group has reported a strong performance in fiscal year 2017-18, the period ending 30 September 2018. The company said it achieved record-breaking revenue and earnings.
Revenue increased by 9% to €5.817 billion (previous year: €5.348 billion). After currency adjustments, revenue rose by 12%.
Earnings performance helped fully compensate for the unfavorable currency effects.
At €772 million, earnings before interest and taxes (EBIT) were slightly higher than the previous year (€770 million). The EBIT margin was 13%. Order intake increased by 7%, totaling €6.046 billion.
“All Zeiss segments and regions contributed to this result. Our innovative products for the semiconductor industry and medical technology in particular ensured significantly greater, above-market growth dynamics,” commented Professor Dr Michael Kaschke, president and chief executive officer of Zeiss.
“With our consistent focus on innovations, investments and expansion, we have our sights set squarely on our goal of achieving €6 billion in revenue,” Professor Kaschke said, looking ahead to fiscal year 2018-19.